Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Change in Acquisitions & Divestments (2024 - 2025)

Historic Change in Acquisitions & Divestments for Connect Biopharma Holdings (CNTB) over the last 2 years, with Q3 2025 value amounting to $14.4 million.

  • Connect Biopharma Holdings' Change in Acquisitions & Divestments changed N/A to $14.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.7 million, marking a year-over-year change of. This contributed to the annual value of $12.8 million for FY2024, which is 8763.88% down from last year.
  • Latest data reveals that Connect Biopharma Holdings reported Change in Acquisitions & Divestments of $14.4 million as of Q3 2025.
  • Connect Biopharma Holdings' Change in Acquisitions & Divestments' 5-year high stood at $14.4 million during Q3 2025, with a 5-year trough of $2.0 million in Q1 2025.